Gold Nanoparticle Delivery of MicroRNA Impairs Metastasis in Triple-Negative Breast Cancer

lung cancer, thoracic surgery, Neuberger Berman Lung Cancer Research Center, Vivek Mittal

Dr. Vivek Mittal. Credit: John Abbott



Weill Cornell Medicine researchers have shown that giving mice with triple-negative breast cancer therapeutic microRNA (miRNA) in a protective gold nanoparticle results in significantly less spreading of cancer to the lung. Triple-negative breast cancer is a highly aggressive, difficult-to-treat form of the disease, with a high rate of metastatic recurrence. miR-708 is a non-coding microRNA that can block expression of genes that are crucial in metastasis.

To find out more about the article, please click here for details

Weill Cornell Medicine Cardiothoracic Surgery 525 East 68th Street
Box 110
Suite M 404
New York, NY 10065 Directions
Phone: (212) 746-5166